`Filed: January 20, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`COALITION FOR AFFORDABLE DRUGS VI LLC
`
`PETITIONER
`
`v.
`
`CELGENE CORPORATION
`
`PATENT OWNER
`
`___________________
`
`Case No.: IPR2015-01103
`Patent No. 6,315,720
`___________________
`
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICE
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`Coalition for Affordable Drugs VI LLC, the Petitioner, respectfully submits
`
`this Updated Mandatory Notice pursuant to 37 C.F.R. § 42.8(b)(1) to update real
`
`parties-in-interest.
`
`I.
`
`37 C.F.R. § 42.8(b)(1) – Real Parties-in-Interest
`
`
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), Petitioner certifies that Coalition For
`
`Affordable Drugs VI LLC (“CFAD VI”), Hayman Credes Master Fund, L.P.
`
`(“Credes”), Hayman Orange Fund SPC – Portfolio A (“HOF”), Hayman Capital
`
`Master Fund, L.P. (“HCMF”), Hayman Capital Management, L.P. (“HCM”),
`
`Hayman Offshore Management, Inc. (“HOM”), Hayman Investments, L.L.C.
`
`(“HI”), nXn Partners, LLC (“nXnP”), IP Navigation Group, LLC (“IPNav”), J.
`
`Kyle Bass, and Erich Spangenberg are the real parties in interest (collectively,
`
`“RPI”). The RPI hereby certify the following information: Effective as of
`
`December 31, 2015, CFAD VI is a wholly owned subsidiary of Credes, HCMF,
`
`and HOF. Credes is a limited partnership. HOF is a segregated portfolio company.
`
`HCMF is a limited partnership. HCM is the general partner and investment
`
`manager of Credes and HCMF. HCM is the investment manager of HOF. HOM is
`
`the administrative general partner of Credes and HCMF. HI is the general partner
`
`of HCM. J. Kyle Bass is the sole member of HI and sole shareholder of HOM.
`
`CFAD VI, Credes, HOF and HCMF act, directly or indirectly, through HCM as the
`
`general partner and/or investment manager of Credes, HOF and HCMF. nXnP is a
`
`1
`
`
`
`
`paid consultant to HCM. Erich Spangenberg is the 98.5% member of nXnP. IPNav
`
`is a paid consultant to nXnP. Erich Spangenberg is the 98.5% member of IPNav.
`
`Other than HCM and J. Kyle Bass in his capacity as the Chief Investment Officer
`
`of HCM and nXnP and Erich Spangenberg in his capacity as the Manager/CEO of
`
`nXnP, no other person (including any investor, limited partner, or member or any
`
`other person in any of CFAD VI, Credes, HOF, HCMF, HCM, HOM, HI, nXnP or
`
`IPNav) has authority to direct or control (i) the timing of, filing of, content of, or
`
`any decisions or other activities relating to this Petition or (ii) any timing, future
`
`filings, content of, or any decisions or other activities relating to the future
`
`proceedings related to this Petition. All of the costs associated with this Petition
`
`will be borne by HCM, CFAD VI, Credes, HOF and/or HCMF.
`
`
`Date: January 20, 2016
`
`
`
`
`
`
`
`2
`
`
`Respectfully submitted,
`
`
`
`
`/Sarah E. Spires/
`Sarah E. Spires (Reg. No. 61,501)
`Dr. Parvathi Kota (Reg. No. 65,122)
`Paul J. Skiermont (pro hac vice)
`SKIERMONT DERBY LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, TX 75201
`Tel: (214) 978-6600
`Fax: (214) 978-6601
`1103CFAD6@skiermontderby.com
`
`Attorneys for Petitioner
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on January 20, 2016, a
`
`true and correct copy of the foregoing Petitioner’s Updated Mandatory Notice
`
`Pursuant to 37 C.F.R. § 42.8(b)(3), was served by filing this document through the
`
`Patent Review Processing System, as well as emailing copies to
`
`nickcerrito@quinnemanuel.com and aminsogna@jonesday.com.
`
`/Sarah E. Spires/
`Sarah E. Spires
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: January 20, 2016